HOME ·

Hengrui Pharmaceuticals

Hengrui Pharmaceuticals (01276.HK): NDA for HRG2010 Capsules Accepted
Tags：
Hengrui Pharmaceuticals01276.HK
2026-08-25
Hengrui Pharmaceuticals (01276.HK): SHR-4375 Injection Granted FDA Orphan Drug Designation
Tags：
Hengrui Pharmaceuticals01276.HK
2026-07-28
Hengrui Pharmaceuticals (01276.HK): HRS-1780 Tablets Obtains Clinical Trial Approval Notice
Tags：
Hengrui Pharmaceuticals01276.HK
2026-07-28
Hengrui Pharmaceuticals(01276.HK): Injection HRS9531 Obtains Clinical Trial Approval Notice
Tags：
Hengrui Pharmaceuticals01276.HK
2026-07-16
Hengrui Pharmaceuticals(01276.HK): Concentrated Solution for Injection HRS-8829 Receives Clinical Trial Approval Notice
Tags：
Hengrui Pharmaceuticals01276.HK
2026-07-15
Hengrui Pharmaceuticals(01276.HK): Injection SHR-3079 Obtains Clinical Trial Approval Notice
Tags：
Hengrui Pharmaceuticals01276.HK
2026-07-13